Influenza

>

Latest News

Pfizer BioNTech Topline Data Show Robust Immune Response for COVID-19/Influenza Vaccine Combination  / image credit flu and C19 viruses ©Kateryna_Kon/stock.adobe.com
Pfizer BioNTech Topline Data Show Robust Immune Response for COVID-19/Influenza Vaccine Combination

October 31st 2023

The mRNA-based combination vaccine candidate for flu and COVID-19 received Fast Track Designation from the US Food and Drug Administration.

Daily Dose: "Night Owls" Less Healthy, at Higher Risk for T2D / image credit folders-stethoscope  ©New Africa/AdobeStock
Daily Dose: Coadministration of RSV and Flu Vaccines in Older Adults

October 19th 2023

Influenza Vaccination in Older US Adults Linked to Reduction of Severe Complications, Enhanced Vaccine Furthers Clinical Benefits / Image credit: ©Studio Romantic/AdobeStock
IDWeek 2023: Influenza Vaccination in Older US Adults Linked to Reduction of Severe Complications, Enhanced Vaccine Furthers Clinical Benefits

October 14th 2023

Coadministration of RSV, Influenza Vaccines is Safe and Effective in Older Adults, Study Finds Image credits  RSV ©Artur/stock.adobe.com influenza ©Kateryna_Kon/stock.adobe.com
Coadministration of RSV, Influenza Vaccines is Safe and Effective in Older Adults, Study Finds

October 14th 2023

Seasonal Flu Vaccine Offers More Protection for Immunocompetent Adults than Immunocompromised Peers, but “Difference not Statistically Significant” / Image credit: ©leigh prather/AdobeStock
IDWeek 2023: Seasonal Flu Vaccine Offers More Protection for Immunocompetent Adults than Immunocompromised Peers, but “Difference not Statistically Significant”

October 11th 2023

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.